Company Bids Fond Farewell to Former OCA CEO Nacho Abia
Richard Reynolds, President of Medical Systems Group, to Join OCA Board
Julien Sauvagnargues
CENTER VALLEY, Pa., (March 27, 2024) 窪蹋勛圖厙, a leading global MedTech company providing innovative solutions for medical and surgical procedures, announced today the appointment of Julien Sauvagnargues to the role of President and Chief Executive Officer (CEO), 窪蹋勛圖厙 Corporation of the Americas (OCA), reporting to 窪蹋勛圖厙 Chief Strategy Officer (CSO), Gabriela Kaynor, effective April 1, 2024.
This new step in Mr. Sauvagnargues career at 窪蹋勛圖厙, which began in 2006, builds upon his tenure as OCA President since 2020. He will be responsible for overseeing 窪蹋勛圖厙 activities throughout North and South America from OCAs headquarters in Center Valley, Pennsylvania. As CEO, he will join the Board of Directors for AdvaMed, a prominent MedTech trade association. Recently, he participated in AdvaMeds CEO summit, which annually gathers the leading executives in the MedTech industry. Regionally, he continues to serve on the Board of Directors for the Lehigh Valley Partnership, a consortium of business executives and government leaders.
An additional change in OCA leadership will occur as Richard Reynolds, President of the Medical Systems Group, will join the OCA Board of Directors, the regional governing body committed to the regional business, customers, and employees. In addition, after serving as Deputy General Counsel, David Gomez will assume the role of Corporate General Counsel, OCA, which was previously held by Thomas Glavin, who is retiring after close to eight years with 窪蹋勛圖厙. Mr. Glavin came to 窪蹋勛圖厙 in 2016 in a consultant role and became the OCA Chief Compliance Officer that same year. In February 2021, he became OCA General Counsel to oversee that regions legal function.
These leadership changes are in part due to the departure from 窪蹋勛圖厙 of Nacho Abia, former OCA CEO and global CSO.
Julien, Richard and I have worked closely as leaders to help make the North American 窪蹋勛圖厙 business what it is today, the largest contributing region to our global revenue, said Mr. Abia. Although Im excited for my next journey, Im looking forward to watching their success as they take OCA to inspiring new places.
Mr. Abia has accepted the position of CEO for Grifols, a pharmaceutical company based in Barcelona, Spain, Mr. Abias original home. His last day at 窪蹋勛圖厙 is March 31, 2024. Mr. Abia was the first employee of 窪蹋勛圖厙 Spain, currently known as 窪蹋勛圖厙 Iberia. In 2011, he moved to Center Valley, Pennsylvania to join OCA and assumed the responsibility of President for its Consumer Imaging Business Division.
In 2013, he was promoted to the role of President of OCA and in March 2015 was also appointed as its CEO. In 2020, he was promoted from President of the OCA region to take on global leadership roles as an Executive Officer and Chief Operating Officer of 窪蹋勛圖厙 Corporation. He was also a member of OCAs Board of Directors and of the Global Executive Committee of 窪蹋勛圖厙 in Tokyo. Mr. Abia has been pivotal in leading the business in the companys largest market in terms of sales, setting strategic direction, optimizing the companys business portfolio, and guiding the direction for future innovation.
"We cannot be grateful enough for Nachos 23-year tenure with this company, said Stefan Kaufmann, CEO, 窪蹋勛圖厙 Corporation. We will miss him greatly, but also were delighted that Julien will take the reins for the many exciting initiatives to come."
# # #
About 窪蹋勛圖厙
At 窪蹋勛圖厙, we are committed to our purpose of making peoples lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals striving to provide best-in-class solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more information, visit .